72
Informaciones
Psiquiátricas
2015 - n.º 220
Anna Prats
28. Prats A, Guerra H, Crespo MC, Del Hoyo
L, Nieto I, Bayés A. Controversial
mild cognitive impairment criteria in
Parkinson’s disease. 2011 Mov Disord.
26 (Suppl 2), S159.
29. Liepelt-Scarfone I, Graeber S, Feseker A,
Baysal G, Godau J, Gaenslen A, et al.
Influence of different cut-off values on
the diagnosis of mild cognitive impair-
ment in Parkinson’s disease. Parkinsons
Dis. 2011;2011:540843.
30. Goldman JG, Holden S, Bernard B, Ou-
yang B, Goetz CG, Stebbins GT. Defining
optimal cutoff scores for cognitive im-
pairment using Movement Disorder So-
ciety Task Force criteria for mild cogni-
tive impairment in Parkinson’s disease.
Mov Disord. 2013 Dec;28(14):1972-9.
31. Kehagia AA, Barker RA, Robbins TW.
Neuropsychological and clinical he-
terogeneity of cognitive impair-
ment and dementia in patients with
Parkinson’s disease. Lancet Neurol. 2010
Dec;9(12):1200-13.
32. Schretlen DJ, Testa SM, Winicki JM,
Pearlson GD, Gordon B. Frequency and
bases of abnormal performance by
healthy adults on neuropsychological
testing. J Int Neuropsychol Soc. 2008
May;14(3):436-45.
33. Marras C, Armstrong MJ, Meaney CA,
Fox S, Rothberg B, Reginold W, et al.
Measuring mild cognitive impairment in
patients with Parkinson’s disease. Mov
Disord. 2013 May;28(5):626-33.
34. Williams-Gray CH, Foltynie T, Brayne
CE, Robbins TW, Barker RA. Evolution
of cognitive dysfunction in an incident
Parkinson’s disease cohort. Brain. 2007
Jul;130(Pt 7):1787-98.
35. Williams-Gray CH, Evans JR, Goris A, Fol-
tynie T, Ban M, Robbins TW, Brayne C,
et al. The distinct cognitive syndromes
of Parkinson’s disease: 5 year follow-
up of the CamPaIGN cohort. Brain.2009
Nov;132(Pt 11):2958-69.
36. Cholerton BA, Zabetian CP, Wan JY, Mon-
tine TJ, Quinn JF, Mata IF, et al. Eva-
luation of mild cognitive impairment
subtypes in Parkinson’s disease. Mov
Disord. 2014 May;29(6):756-64.
